In patients with AML, some types of gene mutations such as FLT3-ITD, overexpression of some chemo-resistance-related enzymes such as acid ceramidase, and autophagy signaling pathways, lead to relapse and chemo-resistance. Here, ASAH1 is linked to acute myeloid leukemia.